HEADER SIGNALING PROTEIN 23-FEB-23 8CNH TITLE CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE (SAC) IN COMPLEX TITLE 2 WITH INHIBITOR TDI-10512 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENYLATE CYCLASE TYPE 10; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AH-RELATED PROTEIN,ADENYLATE CYCLASE HOMOLOG,GERM CELL COMPND 5 SOLUBLE ADENYLYL CYCLASE,SAC,TESTICULAR SOLUBLE ADENYLYL CYCLASE; COMPND 6 EC: 4.6.1.1; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: DISULFID WITH MERCAPTOETHANOL AT CYS255 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADCY10, SAC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CAMP, ADENYLYL CYCLASE, INHIBITOR, CATALYTIC DOMAIN, SIGNALING KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.STEEGBORN REVDAT 2 17-MAY-23 8CNH 1 JRNL REVDAT 1 26-APR-23 8CNH 0 JRNL AUTH S.SUN,M.FUSHIMI,T.ROSSETTI,N.KAUR,J.FERREIRA,M.MILLER, JRNL AUTH 2 J.QUAST,J.VAN DEN HEUVEL,C.STEEGBORN,L.R.LEVIN,J.BUCK, JRNL AUTH 3 R.W.MYERS,S.KARGMAN,N.LIVERTON,P.T.MEINKE,D.J.HUGGINS JRNL TITL SCAFFOLD HOPPING AND OPTIMIZATION OF SMALL MOLECULE SOLUBLE JRNL TITL 2 ADENYL CYCLASE INHIBITORS LED BY FREE ENERGY PERTURBATION. JRNL REF J.CHEM.INF.MODEL. V. 63 2828 2023 JRNL REFN ESSN 1549-960X JRNL PMID 37060320 JRNL DOI 10.1021/ACS.JCIM.2C01577 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.15.2_3472 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.38 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 35926 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1798 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.3800 - 4.7000 1.00 2788 148 0.1745 0.2198 REMARK 3 2 4.7000 - 3.7300 1.00 2777 146 0.1367 0.1864 REMARK 3 3 3.7300 - 3.2600 1.00 2744 144 0.1613 0.2272 REMARK 3 4 3.2600 - 2.9600 1.00 2750 145 0.1855 0.2430 REMARK 3 5 2.9600 - 2.7500 1.00 2735 144 0.1996 0.2296 REMARK 3 6 2.7500 - 2.5900 1.00 2765 145 0.2006 0.2416 REMARK 3 7 2.5900 - 2.4600 1.00 2728 144 0.2151 0.2620 REMARK 3 8 2.4600 - 2.3500 1.00 2743 144 0.2270 0.2789 REMARK 3 9 2.3500 - 2.2600 1.00 2706 143 0.2453 0.2850 REMARK 3 10 2.2600 - 2.1800 1.00 2756 145 0.2749 0.3132 REMARK 3 11 2.1800 - 2.1100 0.99 2693 142 0.3036 0.3334 REMARK 3 12 2.1100 - 2.0500 0.85 2341 130 0.3172 0.3440 REMARK 3 13 2.0500 - 2.0000 0.58 1602 78 0.3542 0.3572 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.297 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.179 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.83 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.018 3761 REMARK 3 ANGLE : 1.474 5072 REMARK 3 CHIRALITY : 0.079 556 REMARK 3 PLANARITY : 0.010 644 REMARK 3 DIHEDRAL : 6.261 3045 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 7 THROUGH 88 ) REMARK 3 ORIGIN FOR THE GROUP (A): -37.4974 11.8528 3.3898 REMARK 3 T TENSOR REMARK 3 T11: 0.2558 T22: 0.2250 REMARK 3 T33: 0.2466 T12: 0.0115 REMARK 3 T13: 0.0204 T23: -0.0016 REMARK 3 L TENSOR REMARK 3 L11: 2.3913 L22: 1.4586 REMARK 3 L33: 1.4449 L12: -0.9412 REMARK 3 L13: 0.4142 L23: -0.1612 REMARK 3 S TENSOR REMARK 3 S11: 0.0659 S12: 0.0579 S13: -0.2423 REMARK 3 S21: 0.1099 S22: 0.0003 S23: 0.0385 REMARK 3 S31: 0.1124 S32: -0.0057 S33: -0.0628 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 89 THROUGH 287 ) REMARK 3 ORIGIN FOR THE GROUP (A): -30.8629 6.6316 11.5648 REMARK 3 T TENSOR REMARK 3 T11: 0.3144 T22: 0.2599 REMARK 3 T33: 0.2861 T12: 0.0344 REMARK 3 T13: -0.0245 T23: 0.0136 REMARK 3 L TENSOR REMARK 3 L11: 1.5006 L22: 2.3010 REMARK 3 L33: 2.6129 L12: -0.3330 REMARK 3 L13: -0.0220 L23: -0.8897 REMARK 3 S TENSOR REMARK 3 S11: -0.0659 S12: -0.2204 S13: -0.1447 REMARK 3 S21: 0.1298 S22: 0.1179 S23: -0.0097 REMARK 3 S31: 0.4076 S32: 0.0331 S33: -0.0497 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 288 THROUGH 398 ) REMARK 3 ORIGIN FOR THE GROUP (A): -27.6185 5.6556 -13.6223 REMARK 3 T TENSOR REMARK 3 T11: 0.3052 T22: 0.2866 REMARK 3 T33: 0.2974 T12: 0.0653 REMARK 3 T13: 0.0402 T23: -0.0025 REMARK 3 L TENSOR REMARK 3 L11: 1.6458 L22: 1.8177 REMARK 3 L33: 2.9882 L12: 0.4361 REMARK 3 L13: -0.6184 L23: 1.2627 REMARK 3 S TENSOR REMARK 3 S11: -0.0232 S12: 0.3095 S13: -0.0804 REMARK 3 S21: -0.1496 S22: 0.0382 S23: -0.1920 REMARK 3 S31: 0.1058 S32: 0.2229 S33: -0.0012 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 399 THROUGH 468 ) REMARK 3 ORIGIN FOR THE GROUP (A): -35.2130 -3.6406 -18.2906 REMARK 3 T TENSOR REMARK 3 T11: 0.4691 T22: 0.3903 REMARK 3 T33: 0.3659 T12: 0.0087 REMARK 3 T13: 0.0223 T23: -0.0491 REMARK 3 L TENSOR REMARK 3 L11: 0.4151 L22: 2.9704 REMARK 3 L33: 2.2862 L12: -0.5034 REMARK 3 L13: -0.4149 L23: 2.1387 REMARK 3 S TENSOR REMARK 3 S11: -0.1008 S12: 0.2075 S13: -0.1961 REMARK 3 S21: -0.1780 S22: -0.1809 S23: 0.3368 REMARK 3 S31: 0.3538 S32: -0.1276 S33: 0.2009 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8CNH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1292128821. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-AUG-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36970 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 44.380 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 10.40 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 64.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE PH 4.8, 0.2 M REMARK 280 TRISODIUM CITRATE, 15%(W/V) PEG 4000, 10%(V/V) GLYCEROL, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 49.80050 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 49.80050 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 49.80050 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASN A 2 REMARK 465 THR A 3 REMARK 465 PRO A 4 REMARK 465 LYS A 5 REMARK 465 GLU A 6 REMARK 465 THR A 132 REMARK 465 GLN A 133 REMARK 465 GLU A 134 REMARK 465 TRP A 135 REMARK 465 GLU A 136 REMARK 465 GLU A 137 REMARK 465 GLY A 138 REMARK 465 LEU A 139 REMARK 465 ASP A 140 REMARK 465 VAL A 469 REMARK 465 HIS A 470 REMARK 465 HIS A 471 REMARK 465 HIS A 472 REMARK 465 HIS A 473 REMARK 465 HIS A 474 REMARK 465 HIS A 475 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 56 CG CD OE1 OE2 REMARK 470 LYS A 57 CG CD CE NZ REMARK 470 MET A 184 CG SD CE REMARK 470 GLU A 353 CG CD OE1 OE2 REMARK 470 LYS A 354 CG CD CE NZ REMARK 470 ASN A 436 CG OD1 ND2 REMARK 470 ARG A 465 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 468 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 84 CB GLU A 84 CG -0.136 REMARK 500 SER A 456 CA SER A 456 CB -0.092 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 22 CB - CG - OD2 ANGL. DEV. = -6.7 DEGREES REMARK 500 CYS A 193 CA - CB - SG ANGL. DEV. = 8.1 DEGREES REMARK 500 ASP A 278 CB - CG - OD1 ANGL. DEV. = -5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 159 -166.15 -118.12 REMARK 500 ASN A 185 2.11 83.57 REMARK 500 ASP A 258 89.72 -164.66 REMARK 500 GLN A 283 0.43 -66.10 REMARK 500 GLU A 353 41.34 -140.19 REMARK 500 LYS A 378 -9.62 81.85 REMARK 500 ASN A 436 52.03 -90.97 REMARK 500 ASP A 455 77.30 35.74 REMARK 500 SER A 456 -39.62 -23.71 REMARK 500 REMARK 500 REMARK: NULL DBREF 8CNH A 1 469 UNP Q96PN6 ADCYA_HUMAN 1 469 SEQADV 8CNH HIS A 470 UNP Q96PN6 EXPRESSION TAG SEQADV 8CNH HIS A 471 UNP Q96PN6 EXPRESSION TAG SEQADV 8CNH HIS A 472 UNP Q96PN6 EXPRESSION TAG SEQADV 8CNH HIS A 473 UNP Q96PN6 EXPRESSION TAG SEQADV 8CNH HIS A 474 UNP Q96PN6 EXPRESSION TAG SEQADV 8CNH HIS A 475 UNP Q96PN6 EXPRESSION TAG SEQRES 1 A 475 MET ASN THR PRO LYS GLU GLU PHE GLN ASP TRP PRO ILE SEQRES 2 A 475 VAL ARG ILE ALA ALA HIS LEU PRO ASP LEU ILE VAL TYR SEQRES 3 A 475 GLY HIS PHE SER PRO GLU ARG PRO PHE MET ASP TYR PHE SEQRES 4 A 475 ASP GLY VAL LEU MET PHE VAL ASP ILE SER GLY PHE THR SEQRES 5 A 475 ALA MET THR GLU LYS PHE SER SER ALA MET TYR MET ASP SEQRES 6 A 475 ARG GLY ALA GLU GLN LEU VAL GLU ILE LEU ASN TYR HIS SEQRES 7 A 475 ILE SER ALA ILE VAL GLU LYS VAL LEU ILE PHE GLY GLY SEQRES 8 A 475 ASP ILE LEU LYS PHE ALA GLY ASP ALA LEU LEU ALA LEU SEQRES 9 A 475 TRP ARG VAL GLU ARG LYS GLN LEU LYS ASN ILE ILE THR SEQRES 10 A 475 VAL VAL ILE LYS CYS SER LEU GLU ILE HIS GLY LEU PHE SEQRES 11 A 475 GLU THR GLN GLU TRP GLU GLU GLY LEU ASP ILE ARG VAL SEQRES 12 A 475 LYS ILE GLY LEU ALA ALA GLY HIS ILE SER MET LEU VAL SEQRES 13 A 475 PHE GLY ASP GLU THR HIS SER HIS PHE LEU VAL ILE GLY SEQRES 14 A 475 GLN ALA VAL ASP ASP VAL ARG LEU ALA GLN ASN MET ALA SEQRES 15 A 475 GLN MET ASN ASP VAL ILE LEU SER PRO ASN CYS TRP GLN SEQRES 16 A 475 LEU CYS ASP ARG SER MET ILE GLU ILE GLU SER VAL PRO SEQRES 17 A 475 ASP GLN ARG ALA VAL LYS VAL ASN PHE LEU LYS PRO PRO SEQRES 18 A 475 PRO ASN PHE ASN PHE ASP GLU PHE PHE THR LYS CYS THR SEQRES 19 A 475 THR PHE MET HIS TYR TYR PRO SER GLY GLU HIS LYS ASN SEQRES 20 A 475 LEU LEU ARG LEU ALA CME THR LEU LYS PRO ASP PRO GLU SEQRES 21 A 475 LEU GLU MET SER LEU GLN LYS TYR VAL MET GLU SER ILE SEQRES 22 A 475 LEU LYS GLN ILE ASP ASN LYS GLN LEU GLN GLY TYR LEU SEQRES 23 A 475 SER GLU LEU ARG PRO VAL THR ILE VAL PHE VAL ASN LEU SEQRES 24 A 475 MET PHE GLU ASP GLN ASP LYS ALA GLU GLU ILE GLY PRO SEQRES 25 A 475 ALA ILE GLN ASP ALA TYR MET HIS ILE THR SER VAL LEU SEQRES 26 A 475 LYS ILE PHE GLN GLY GLN ILE ASN LYS VAL PHE MET PHE SEQRES 27 A 475 ASP LYS GLY CYS SER PHE LEU CYS VAL PHE GLY PHE PRO SEQRES 28 A 475 GLY GLU LYS VAL PRO ASP GLU LEU THR HIS ALA LEU GLU SEQRES 29 A 475 CYS ALA MET ASP ILE PHE ASP PHE CYS SER GLN VAL HIS SEQRES 30 A 475 LYS ILE GLN THR VAL SER ILE GLY VAL ALA SER GLY ILE SEQRES 31 A 475 VAL PHE CYS GLY ILE VAL GLY HIS THR VAL ARG HIS GLU SEQRES 32 A 475 TYR THR VAL ILE GLY GLN LYS VAL ASN LEU ALA ALA ARG SEQRES 33 A 475 MET MET MET TYR TYR PRO GLY ILE VAL THR CYS ASP SER SEQRES 34 A 475 VAL THR TYR ASN GLY SER ASN LEU PRO ALA TYR PHE PHE SEQRES 35 A 475 LYS GLU LEU PRO LYS LYS VAL MET LYS GLY VAL ALA ASP SEQRES 36 A 475 SER GLY PRO LEU TYR GLN TYR TRP GLY ARG THR GLU LYS SEQRES 37 A 475 VAL HIS HIS HIS HIS HIS HIS MODRES 8CNH CME A 253 CYS MODIFIED RESIDUE HET CME A 253 19 HET V6U A 501 41 HET DMS A 502 10 HET DMS A 503 10 HET DMS A 504 10 HET EDO A 505 10 HET DMS A 506 10 HET EDO A 507 10 HET EDO A 508 10 HET EDO A 509 10 HET EDO A 510 10 HET EDO A 511 10 HET DMS A 512 10 HET ACT A 513 7 HET EDO A 514 10 HET EDO A 515 10 HET EDO A 516 10 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM V6U METHYL 2-[[3-(2-AZANYL-6-CHLORANYL-PYRIMIDIN-4-YL)-1- HETNAM 2 V6U METHYL-PYRAZOL-4-YL]METHYL]BENZOATE HETNAM DMS DIMETHYL SULFOXIDE HETNAM EDO 1,2-ETHANEDIOL HETNAM ACT ACETATE ION HETSYN EDO ETHYLENE GLYCOL FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 V6U C17 H16 CL N5 O2 FORMUL 3 DMS 5(C2 H6 O S) FORMUL 6 EDO 9(C2 H6 O2) FORMUL 14 ACT C2 H3 O2 1- FORMUL 18 HOH *125(H2 O) HELIX 1 AA1 TRP A 11 ALA A 18 1 8 HELIX 2 AA2 PRO A 21 TYR A 26 1 6 HELIX 3 AA3 GLY A 50 SER A 59 1 10 HELIX 4 AA4 SER A 60 MET A 64 5 5 HELIX 5 AA5 ARG A 66 PHE A 89 1 24 HELIX 6 AA6 GLU A 108 LYS A 110 5 3 HELIX 7 AA7 GLN A 111 LEU A 129 1 19 HELIX 8 AA8 GLY A 169 ALA A 182 1 14 HELIX 9 AA9 SER A 190 CYS A 197 1 8 HELIX 10 AB1 ASN A 225 THR A 235 1 11 HELIX 11 AB2 SER A 242 LYS A 246 5 5 HELIX 12 AB3 ARG A 250 LEU A 255 5 6 HELIX 13 AB4 ASP A 258 LYS A 267 1 10 HELIX 14 AB5 MET A 270 ASP A 278 1 9 HELIX 15 AB6 LYS A 306 GLN A 329 1 24 HELIX 16 AB7 ASP A 357 SER A 374 1 18 HELIX 17 AB8 GLY A 408 TYR A 421 1 14 HELIX 18 AB9 ASP A 428 SER A 435 1 8 HELIX 19 AC1 PRO A 438 TYR A 440 5 3 SHEET 1 AA1 5 ASP A 92 ALA A 97 0 SHEET 2 AA1 5 ALA A 100 ARG A 106 -1 O ALA A 100 N ALA A 97 SHEET 3 AA1 5 PHE A 35 ILE A 48 -1 N MET A 44 O ALA A 103 SHEET 4 AA1 5 VAL A 143 GLY A 158 -1 O ILE A 152 N PHE A 39 SHEET 5 AA1 5 SER A 163 ILE A 168 -1 O ILE A 168 N SER A 153 SHEET 1 AA2 7 ASP A 92 ALA A 97 0 SHEET 2 AA2 7 ALA A 100 ARG A 106 -1 O ALA A 100 N ALA A 97 SHEET 3 AA2 7 PHE A 35 ILE A 48 -1 N MET A 44 O ALA A 103 SHEET 4 AA2 7 VAL A 143 GLY A 158 -1 O ILE A 152 N PHE A 39 SHEET 5 AA2 7 VAL A 187 LEU A 189 1 O ILE A 188 N LEU A 147 SHEET 6 AA2 7 VAL A 213 LEU A 218 -1 O VAL A 213 N LEU A 189 SHEET 7 AA2 7 ILE A 202 SER A 206 -1 N GLU A 203 O PHE A 217 SHEET 1 AA3 5 GLY A 330 PHE A 338 0 SHEET 2 AA3 5 GLY A 341 PHE A 348 -1 O LEU A 345 N ASN A 333 SHEET 3 AA3 5 GLU A 288 MET A 300 -1 N VAL A 297 O PHE A 344 SHEET 4 AA3 5 THR A 381 HIS A 398 -1 O ALA A 387 N ILE A 294 SHEET 5 AA3 5 ARG A 401 ILE A 407 -1 O ARG A 401 N HIS A 398 SHEET 1 AA4 7 GLY A 330 PHE A 338 0 SHEET 2 AA4 7 GLY A 341 PHE A 348 -1 O LEU A 345 N ASN A 333 SHEET 3 AA4 7 GLU A 288 MET A 300 -1 N VAL A 297 O PHE A 344 SHEET 4 AA4 7 THR A 381 HIS A 398 -1 O ALA A 387 N ILE A 294 SHEET 5 AA4 7 VAL A 425 CYS A 427 1 O THR A 426 N ILE A 384 SHEET 6 AA4 7 TYR A 460 TYR A 462 -1 O TYR A 460 N CYS A 427 SHEET 7 AA4 7 PHE A 442 GLU A 444 -1 N LYS A 443 O GLN A 461 LINK C ALA A 252 N CME A 253 1555 1555 1.33 LINK C CME A 253 N THR A 254 1555 1555 1.32 CISPEP 1 ARG A 33 PRO A 34 0 3.07 CRYST1 99.140 99.140 99.601 90.00 90.00 120.00 P 63 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010087 0.005824 0.000000 0.00000 SCALE2 0.000000 0.011647 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010040 0.00000